logo
  

Hut 8 Mining To Combine With US Bitcoin In All-stock Merger Of Equals

Digital asset miner Hut 8 Mining Corp. (HUT, HUT.TO) on Thursday agreed to a proposed business combination with U.S. Data Mining Group, Inc. dba US Bitcoin Corp (USBTC) under which they will combine in an all-stock merger of equals.

The combined company will be named "Hut 8 Corp." and will be a U.S.-domiciled entity. The transaction is expected to establish the combined entity as a large scale, publicly traded Bitcoin miner focused on economical mining, highly diversified revenue streams, and industry leading environmental, social, and governance (ESG) practices.

The combined entity has filed a further amendment to its Form S-4 Registration Statement with the U.S. Securities and Exchange Commission with the expected installed self-mining capacity increased to 7.5 EH/s from the previously disclosed 7.02 EH/s at mining facilities in Medicine Hat and Drumheller in Alberta; Niagara Falls, New York; Kearney, Nebraska; and Granbury and King Mountain, Texas upon the close of the transaction.

The improvement is due to the energization of additional miners at USBTC's sites. The 1.7 EH/s installed self-mining capacity at the King Mountain, Texas site is owned by the joint venture in which USBTC has a 50% membership interest alongside a leading energy partner.

The completion of the transaction remains subject to the remaining regulatory approvals, shareholder approval, court approval, and other customary closing conditions of the transaction.

For comments and feedback contact: editorial@rttnews.com

Business News

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
Follow RTT